Extracellular YB-1 blockade in experimental nephritis upregulates Notch-3 receptor expression and signaling

Nephron - Experimental Nephrology

Volumn 118, Issue 4, 2011, Pages

  Raffetseder, Ute ^a   Rauen, Thomas ^a   Boor, Peter ^a   Ostendorf, Tammo ^a   Hanssen, Lydia ^a   Floege, Jürgen ^a   En Nia, Abdelaziz ^b   Djudjaj, Sonja ^a   Frye, Björn C ^a   Mertens, Peter R ^b  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Anti Thy1.1 nephritis; Mesangioproliferative nephritis; Notch signaling; Y box protein 1

Indexed keywords

NOTCH3 RECEPTOR; Y BOX BINDING PROTEIN 1;

ALLELE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE ACTIVATION; MESANGIUM CELL; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; UPREGULATION;

ALLELES; ANIMALS; EXTRACELLULAR SPACE; GENE TARGETING; KIDNEY GLOMERULUS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEPHRITIS; RATS; RATS, WISTAR; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; UP-REGULATION; Y-BOX-BINDING PROTEIN 1;

EID: 79952105896     PISSN: 16602129     EISSN: 16602110     Source Type: Journal    
DOI: 10.1159/000324209     Document Type: Article

References (27)

1. Fortini ME: Notch signaling: The core pathway and its posttranslational regulation. Dev Cell 2009; 16: 633-647.
2. De Strooper B, Annaert W, Cupers P, et al: A presenilin-1-dependent gamma-secretaselike protease mediates release of Notch intracellular domain. Nature 1999; 398: 518-522.
3. Iso T, Hamamori Y, Kedes L: Notch signaling in vascular development. Arterioscler Thromb Vasc Biol 2003; 23: 543-553. (Pubitemid 36438065)
4. Niranjan T, Bielesz B, Gruenwald A, et al: The Notch pathway in podocytes plays a role in the development of glomerular disease. Nat Med 2008; 14: 290-298. (Pubitemid 351347919)
5. Waters AM, Wu MY, Onay T, et al: Ectopic notch activation in developing podocytes causes glomerulosclerosis. J Am Soc Nephrol 2008; 19: 1139-1157.
6. Cheng HT, Kopan R: The role of Notch signaling in specification of podocyte and proximal tubules within the developing mouse kidney. Kidney Int 2005; 68: 1951-1952. (Pubitemid 43117769)
7. Kobayashi T, Terada Y, Kuwana H, et al: Expression and function of the Delta-1/ Notch-2/Hes-1 pathway during experimental acute kidney injury. Kidney Int 2008; 73: 1240-1250. (Pubitemid 351693161)
8. Rauen T, Raffetseder U, Frye BC, et al: YB-1 acts as ligand for Notch-3 receptors and modulates receptor activation. J Biol Chem 2009; 284: 26928-26940.
9. Mertens PR, Steinmann K, Alfonso-Jaume MA, et al: Combinatorial interactions of p53, activating protein-2, and YB-1 with a single enhancer element regulate gelatinase A expression in neoplastic cells. J Biol Chem 2002; 277: 24875-24882. (Pubitemid 34951788)
10. Raffetseder U, Rauen T, Djudjaj S, et al: Differential regulation of chemokine CCL5 expression in monocytes/macrophages and renal cells by Y-box protein-1. Kidney Int 2008; 75: 185-196.
11. Raffetseder U, Frye BC, Rauen T, et al: Splicing factor SRp30c interaction with Y-box protein-1 confers nuclear YB-1 shuttling and alternative splice site selection. J Biol Chem 2003; 278: 18241-18248. (Pubitemid 36799442)
12. Chen CY, Gherzi R, Andersen JS, et al: Nucleolin and YB-1 are required for JNK-mediated interleukin-2 mRNA stabilization during T-cell activation. Genes Dev 2000; 14: 1236-1248. (Pubitemid 30327504)
13. Lu ZH, Books JT, Ley T: YB-1 is important for late-stage embryonic development, optimal cellular stress responses, and the prevention of premature senescence. MCB 2005; 11: 4625-4637. (Pubitemid 40705766)
14. Frye BC, Halfter S, Djudjaj S, et al: Y-box protein-1 is actively secreted through a nonclassical pathway and acts as an extracellular mitogen. EMBO Rep 2009; 10: 783-789.
15. Floege J, Ostendorf T, Janssen U, et al: Novel approach to specific growth factor inhibition in vivo: Antagonism of platelet-derived growth factor in glomerulonephritis by aptamers. Am J Pathol 1999; 154: 169-179. (Pubitemid 29031624)
16. Dahl E, En-Nia A, Wiesmann F, et al: Nuclear detection of Y-box protein-1 (YB-1) closely associates with progesterone receptor negativity and is a strong adverse survival factor in human breast cancer. BMC Cancer 2009; 9: 410.
17. van Roeyen CR, Eitner F, Martinkus S, et al: Y-box protein 1 mediates PDGF-B effects in mesangioproliferative glomerular disease. J Am Soc Nephrol 2005; 16: 2985-2996. (Pubitemid 44743496)
18. Capowski EE, Esnault S, Bhattacharya S, et al: Y box-binding factor promotes eosinophil survival by stabilizing granulocyte-macrophage colony-stimulating factor mRNA. J Immunol 2001; 167: 5970-5976. (Pubitemid 33062794)
19. Joutel A, Andreux F, Gaulis S, et al: The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients. J Clin Invest 2000; 105: 597-605. (Pubitemid 30146506)
20. Ostendorf T, Rong S, Boor P, et al: Antagonism of PDGF-D by human antibody CR002 prevents renal scarring in experimental glomerulonephritis. J Am Soc Nephrol 2006; 17: 1054-1062.
21. Ostendorf T, van Roeyen CR, Peterson JD, et al: A fully human monoclonal antibody (CR002) identifies PDGF-D as a novel mediator of mesangioproliferative glomerulonephritis. J Am Soc Nephrol 2003; 14: 2237-2247. (Pubitemid 37052369)
22. Cove-Smith A, Hendry BM: The regulation of mesangial cell proliferation. Nephron Exp Nephrol 2008; 108: 74-79.
23. Floege J, Eitner F, Alpers CE: A new look at platelet-derived growth factor in renal disease. J Am Soc Nephrol 2008; 19: 12-23.
24. Nekrasov MP, Ivshina MP, Chernov KG, et al: The mRNA-binding protein YB-1 (p50) prevents association of the eukaryotic initiation factor eIF4G with mRNA and inhibits protein synthesis at the initiation stage. J Biol Chem 2003; 278: 13936-13943. (Pubitemid 36799935)
25. Fukuda T, Ashizuka M, Nakamura T, et al: Characterization of the 5α-untranslated region of YB-1 mRNA and autoregulation of translation by YB-1 protein. Nucleic Acids Res 2004; 32: 611-622. (Pubitemid 38263052)
26. Schaefer L, Ren S, Schaefer RM, et al: Nephrin expression is increased in anti-Thy1.1-induced glomerulonephritis in rats. Biochem Biophys Res Commun 1999; 324: 247-254.
27. Sweeney C, Morrow D, Birney YA, et al: Notch 1 and 3 receptor signaling modulates vascular smooth muscle cell growth, apoptosis, and migration via a CBF-1/RBP-Jk dependent pathway. FASEB J 2004; 18: 1421-1423. (Pubitemid 39561601)